Okada Manabu, Hiramitsu Takahisa, Ichimori Toshihiro, Goto Norihiko, Narumi Shunji, Watarai Yoshihiko, Sato Tetsuhiko, Tominaga Yoshihiro
Department of Transplantation and Endocrine Surgery, Nagoya Daini Red Cross Hospital, 2-9 Myoken-cho, Showa-ku, Nagoya, 4668650, Japan.
Department of General Internal Medicine, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
World J Surg. 2020 Feb;44(2):498-507. doi: 10.1007/s00268-019-05124-6.
The effect of parathyroidectomy (PTx) timing on serum calcium (Ca) levels and renal functions in renal transplant recipients with severe hyperparathyroidism (HPT) remains unclear. We retrospectively aimed to investigate and compare the clinical data of patients who underwent pre- and post-transplant PTx and elucidated the impact of PTx timing on serum Ca levels and renal graft outcomes after renal transplantation (RTx).
During January 2000-December 2016, 53 and 55 patients underwent post-transplant PTx (Post-RTx group) and pretransplant PTx (Pre-RTx group), respectively. The serum Ca levels and estimated glomerular filtration rate (eGFR) were assessed in both groups.
At the end of the follow-up, the serum Ca levels were significantly higher and the incidence of hypocalcemia was significantly lower in the Pre-RTx group than in the Post-RTx group [9.5 vs. 8.9 mg/dL, P < 0.001; 14.5% vs. 34.0%, P = 0.024]. The decrease in the eGFR 12-36 months after RTx was more significant in the Post-RTx group than in the Pre-RTx group (-13.8% vs. -0.9%; P = 0.001). A logistic regression involving age, sex, dialysis period, and serum parathormone level revealed that post-transplant PTx is an independent risk factor for persistent hypocalcemia at the end of the follow-up (P = 0.034) and for a >20% decrease in the eGFR 12-36 months after RTx (P = 0.029).
In renal transplant candidates with severe HPT, pretransplant PTx should be considered to prevent persistent hypocalcemia and deterioration of the renal graft function.
对于肾移植受者合并严重甲状旁腺功能亢进(HPT),甲状旁腺切除术(PTx)时机对血清钙(Ca)水平及肾功能的影响尚不清楚。我们进行回顾性研究,旨在调查并比较接受移植前和移植后PTx患者的临床资料,阐明PTx时机对肾移植(RTx)后血清Ca水平及肾移植结局的影响。
2000年1月至2016年12月期间,分别有53例和55例患者接受了移植后PTx(移植后PTx组)和移植前PTx(移植前PTx组)。对两组患者的血清Ca水平及估算肾小球滤过率(eGFR)进行评估。
随访结束时,移植前PTx组的血清Ca水平显著高于移植后PTx组,低钙血症发生率显著低于移植后PTx组[9.5 vs. 8.9mg/dL,P<0.001;14.5% vs. 34.0%,P = 0.024]。RTx后12 - 36个月,移植后PTx组的eGFR下降幅度比移植前PTx组更显著(-13.8% vs. -0.9%;P = 0.001)。一项涉及年龄、性别、透析时间及血清甲状旁腺激素水平的逻辑回归分析显示,移植后PTx是随访结束时持续性低钙血症(P = 0.034)及RTx后12 - 36个月eGFR下降>20%(P = 0.029)的独立危险因素。
对于合并严重HPT的肾移植候选者,应考虑移植前PTx以预防持续性低钙血症及肾移植功能恶化。